Medicine from the nose for pancreatic cancer.

Researchers at Rice University have developed a new method for treating pancreatic cancer by administering Amifostine through the nose, offering protection to healthy cells during radiation therapy. This innovative approach could minimize side effects and improve cancer treatment outcomes.

Medicine from the nose for pancreatic cancer.

The number of cancer patients is increasing day by day. This disease is currently shaking the world. As a result, several research studies are underway. Recently, researchers from Rice University in the USA have developed a new method for the treatment of deadly pancreatic cancer. Pancreatic (pancreatic gland) cancer cells develop near critical organs, such as the small intestine. As a result, radiation therapy with high doses can cause severe digestive system-related problems. Healthy cells near the cancer cells are damaged. However, a drug called Amifostine provides protection to healthy cells during radiation therapy.

So far, this drug, which is administered through injections, has not been widely used due to its significant side effects. When the drug is given orally, stomach acids reduce its effectiveness. To address this, researchers at Rice University have developed a method to administer the drug through the nose. They suggest that it can be directly delivered to the upper part of the digestive tract via a tube inserted into the nose. This could prevent the damage to healthy cells during radiation therapy. When tested on rats, positive results were observed. For more updates on health and cancer-related advancements, you can visit Vaartha.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow